Nonallosteric Sirtuin Activators for Near-Active-Site Binding
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for designing sirtuin enzyme activators are limited by a lack of rational design strategies, particularly for nonallosteric activation of sirtuins like SIRT1, SIRT2, and SIRT6, which are crucial for mammalian longevity, and there is a need for mechanism-based activation that can enhance catalysis.
Innovation Solution
A workflow for discovering nonallosteric sirtuin activators involves high-throughput screening, computational docking, and experimental kinetic measurements to identify compounds that bind near the active site, interacting with flexible protein degrees of freedom, and confirm hit compounds through novel kinetic models.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If allosteric activation is used to decrease substrate Kd, then enzyme activation is achieved, but the method is limited to certain substrates and does not provide general activation strategy
Solution Approach 1:
The patent introduces an intermediary compound that binds to the sirtuin enzyme and facilitates substrate activation through a mediating mechanism rather than direct allosteric modulation. This intermediary approach allows the activator to work with multiple substrate types by creating a generalizable binding interface that does not depend on substrate-specific allosteric sites.
2Adaptability or versatility
If mechanism-based activation is pursued, then general activation strategy is achieved, but the difficulty in screening for balance of properties increases
Solution Approach 1:
The patent applies parameter changes by modifying the binding properties and kinetic characteristics of the activator compound to achieve a balance between activation potency and substrate generality. By systematically varying molecular parameters and screening under controlled conditions, the method reduces the complexity of identifying mechanism-based activators with optimal properties.
3Power
If nonallosteric activators are designed to bind near active site, then catalysis enhancement is achieved, but the binding pocket accessibility and specificity become challenging
Solution Approach 1:
The patent applies local quality by designing activators that bind to specific local regions near the active site with tailored molecular properties. The activator structure is optimized to interact with specific amino acid residues and structural features in the binding pocket, achieving both catalysis enhancement and binding specificity through localized molecular interactions rather than global enzyme modification.
Data Source
AI summary
The present invention provides workflows for the discovery of nonallosteric sirtuin activation compounds. Workflows enable drug discovery of novel sirtuin activating compounds with prescribed effects on the binding in pockets near the active site interacting with flexible protein degrees of freedom around the active site. Novel kinetic models are used to confirm hit compounds and to improve their properties.